Recent news on Guanfacine

Shire Announces Positive Results Of Studies With Guanfacine ...  -  25 May 2007
DentalPlans.com,...“Guanfacine extended release, the first selective alpha-2A-adrenoceptor agonist to be tested in well-controlled studies as a treatment for ADHD,

Analysis Of Ulcerative Colitis (UC) Remission Rates From Long-term ...  -  25 May 2007
Medical News Today (press release),...government regulation and approval, including but not limited to the expected product approval dates of SPD503 (guanfacine extended release) (ADHD) and

Stocks to Watch: Gap, AnnTaylor and Limited Brands  -  May 23, 2007
FOX NewsShire Plc (SHPGY) reported positive results from studies of guanfacine extended release, a potential treatment for attention-deficit/hyperactivity disorder.

Shire to Present New Scientific Data on ADHD Treatment Portfolio ...  -  May 14, 2007
PR Newswire (press release),Additional ADHD treatments under development by Shire include SPD465 (triple-bead mixed amphetamine salts) and SPD503 (guanfacine HCl extended release).

Co-Occurring Mental and Substance Use Disorders: The ...  -  May 18, 2007
Focus (subscription)Preliminary findings indicated that decreasing catecholamine input to the prefrontal cortex by means of 2 -adrenergic agonists such as guanfacine,

Brain Networks Strengthened By Closing Ion Channels  -  Apr 24, 2007
Medical News Today (press release),..."Guanfacine can strengthen the connectivity of these networks by keeping these channels closed, thus improving working memory and reducing distractibility,"

Brain Networks Strengthened by Closing Ion Channels  -  Apr 20, 2007
PR Newswire (press release),These receptors are stimulated by a natural brain chemical- norepinephrine- or by medications like guanfacine. "Guanfacine can strengthen the connectivity

Shire plc: First Quarter Results - Strong Start to the Year With ...  -  Apr 25, 2007
Genetic Engineering News (press release),...government regulation and approval, including but not limited to the expected product approval dates of SPD503 (guanfacine extended release) (ADHD) and

Shire plc: First Quarter Results - Strong Start to the Year With ...  -  Apr 25, 2007
Earthtimes.org...government regulation and approval, including but not limited to the expected product approval dates of SPD503 (guanfacine extended release) (ADHD) and

Shire Completes Acquisition of New River  -  Apr 24, 2007
News-Medical.net,...government regulation and approval, including but not limited to the expected product approval dates of SPD503 (guanfacine extended release) (ADHD) and

Brain Networks Strengthened by Closing Ion Channels  -  Apr 21, 2007
MedIndia,...through into the cell, connecting the network. These receptors are stimulated by a natural brain chemical norepinephrine or by medications like guanfacine.

Shire Pharmaceuticals Extends 'Kidney-Friendly' Cooking Program  -  Apr 10, 2007
Earthtimes.org...government regulation and approval, including but not limited to the expected product approval dates of SPD503 (guanfacine extended release) (ADHD),

Shire and New River Pharmaceuticals Announce FDA Approval of the ...  -  Feb 23, 2007
PR Newswire (press release),...government regulation and approval, including but not limited to the expected product approval dates of SPD503 (guanfacine extended release) (ADHD),

Fosrenol Launches In UK Today - New Option To Control Phosphate ...  -  Feb 22, 2007
Medical News Today (press release),...government regulation and approval, including but not limited to the expected product approval dates of SPD503 (guanfacine extended release) (ADHD),

Shire Agrees to Acquire New River to Gain Full Control of VYVANSE ...  -  Feb 20, 2007
Earthtimes.orgSPD465 (high dose mixed-amphetamine salts for adults) and SPD503 (extended release guanfacine, non-stimulant agent for pediatric use).

FDA Approves LIALDA(TM) (mesalamine), the First Oral Once-Daily ...  -  Jan 16, 2007
PR Newswire (press release),...government regulation and approval, including but not limited to the expected product approval dates of SPD503 (guanfacine extended release) (ADHD),

ELAPRASE(R) for the Treatment of Hunter Syndrome Approved by the ...  -  Jan 10, 2007
Earthtimes.org...government regulation and approval, including but not limited to the expected product approval dates of SPD503 (guanfacine extended release) (ADHD),

No Improvement of Posttraumatic Stress Disorder Symptoms With ...  -  Dec 6, 2006
Am J Psychiatry (subscription)OBJECTIVE: The authors report an 8-week, double-blind, randomized controlled trial of guanfacine versus placebo for posttraumatic stress disorder (PTSD).

Guanfacine in PTSD is no more effective than placebo  -  Dec 3, 2006
RxPG NEWS,By University of California - San Francisco, Guanfacine, a medication commonly prescribed to alleviate symptoms of post-traumatic stress disorder,

Guanfacine no more effective than a placebo  -  Dec 2, 2006
News-Medical.net,Guanfacine, a medication commonly prescribed to alleviate symptoms of post-traumatic stress disorder, is no more effective than a placebo, according to a

Post-trauma drug useless?  -  Dec 4, 2006
Health24.com,In the first-ever randomised, placebo-controlled trial of guanfacine for the alleviation of post-traumatic stress disorder (PTSD), "we found that it really

Common post-traumatic stress disorder drug has "zero" effectiveness  -  Dec 3, 2006
DailyIndia.com,The study, conducted by researchers at the San Francisco VA Medical Center found that Guanfacine does not offer any benefit, but on the contrary has several

Common Post-Traumatic Stress Disorder Drug Is No More Effective ...  -  Dec 1, 2006
DG NewsGuanfacine belongs to a class of medications known as alpha-2 agonists, which lower the brain's supply of the neurotransmitter norepinephrine.

Placebo Equal To PTSD Drug  -  Dec 1, 2006
PsychCentral.com,Guanfacine is often prescribed for PTSD yet researchers from the San Francisco VA Medical Center found the medication was not beneficial and if fact was

New River Pharmaceuticals and Shire Receive Approvable Letter for ...  -  Dec 22, 2006
PharmaLive.com (press release),...government regulation and approval, including but not limited to the expected product approval dates of SPD503 (guanfacine extended release) (ADHD),

PTSD Combat News Roundup: Dec 2006  -  Dec 16, 2006
ePluribus MediaWisconsin's Returning Troops, Senators Call for Army Mental Health Services Investigation, Common PTSD Med Guanfacine As Effective As Placebo,

Wal-Mart $4 Generics Program Launched In Wyoming  -  Nov 27, 2006
Yahoo! News (press release)Furosemide 40MG TAB Furosemide 80MG TAB Guanfacine 1MG TAB Hydralazine 10MG TAB Hydralazine 25MG TAB Hydrochlorothiazide 12.5MG CAP* Hydrochlorothiazide

Shire plc: Excellent Third Quarter With Execution Plan on Track ...  Oct 27, 2006
SPD503 (guanfacine) - ADHD - An NDA was submitted to the FDA on August 24, for investigational compound SPD503 extended release, which, if approved, would be ... -PR Newswire (press release), Lisdexamfetamine dimesylate (NRP104/LDX) is generally well ...  Oct 27, 2006
ADHD franchise; government regulation and approval, including but not limited to the expected product approval dates of SPD503 (guanfacine extended release ... -RxPG NEWS, Wal-Mart Brings $4 Generic Program To Ohio  Oct 26, 2006
TAB Enalapril 10MG TAB Enalapril 2.5MG TAB Enalapril 20MG TAB Enalapril 5MG TAB Furosemide 20MG TAB Furosemide 40MG TAB Furosemide 80MG TAB Guanfacine 1MG TAB ... -PR Newswire (press release), Shire Announces NDA Submission of Guanfacine Extended - Release ...  Aug 27, 2006
...that it has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for its investigational compound guanfacine extended release ... -HealthNewsDigest.com

Shire Seeks Approval for New ADHD Drug  Aug 25, 2006
...broaden its ADHD portfolio, Shire has submitted a new drug application to the FDA seeking approval for its investigational compound, guanfacine extended release ... -International News Service

Shire plc: IFRS Information - First Half of 2006  Sep 18, 2006
...carbonate with or without vitamin D3) CARBATROL® (carbamazepine extended-release capsules) COLAZIDE® (balsalazide) CONNEXYN® (guanfacine extended-release ... -Yahoo! News

Shire plc: IFRS Information - First Half of 2006  Sep 18, 2006
...carbonate with or without vitamin D3) CARBATROL(R) (carbamazepine extended-release capsules) COLAZIDE(R) (balsalazide) CONNEXYN(R) (guanfacine extended-release ... -PR Newswire

Shire seeks FDA approval for ADD drug  Aug 24, 2006
SHPGY), which has headquarters operations both in the United Kingdom and Philadelphia, said it had filed a new drug application for guanfacine extended release ... -Bizjournals.com

Shire seeks OK on nonstimulant ADHD drug  Aug 24, 2006
...drug. Expected to be called Connexyn, the drug for 6- to 17-year-olds will employ guanfacine, an alpha-2A-adrenoceptor agonist. ... -Charlotte Business Journal

Dr Jeffrey Leiden Appointed Non Executive Director at Shire  -  12 Dec 2006
Drug Newswire (press release),...government regulation and approval, including but not limited to the expected product approval dates of SPD503 (guanfacine extended release) (ADHD),

No Improvement of Posttraumatic Stress Disorder Symptoms With ...  -  Dec 6, 2006
Am J Psychiatry (subscription)OBJECTIVE: The authors report an 8-week, double-blind, randomized controlled trial of guanfacine versus placebo for posttraumatic stress disorder (PTSD).

Guanfacine in PTSD is no more effective than placebo  -  Dec 3, 2006
RxPG NEWS,By University of California - San Francisco, Guanfacine, a medication commonly prescribed to alleviate symptoms of post-traumatic stress disorder,

Guanfacine no more effective than a placebo  -  Dec 2, 2006
News-Medical.net,Guanfacine, a medication commonly prescribed to alleviate symptoms of post-traumatic stress disorder, is no more effective than a placebo, according to a

Once-Daily Guanfacine Extended Release in ADHD Patients Aged 6-17  -  Nov 26, 2006
HealthNewsDigest.com,New Orleans – November, 2006 – Shire plc announced that once-daily doses of the investigational medication guanfacine extended release (GXR, also referred

Shire Announces Once-Daily Guanfacine Extended Release Data In ...  -  Nov 23, 2006
Medical News Today (press release),Two additional studies also released at the meeting report the pharmacokinetic profile of guanfacine extended release.

Shire Announces Study Results With Once-Daily Guanfacine Extended ...  -  Nov 16, 2006
Earthtimes.orgShire submitted a New Drug Application (NDA) for guanfacine extended release on August 24, 2006. If approved, guanfacine extended release, which is not a

Shire Announces Study Results With Once-Daily Guanfacine Extended ...  -  Nov 16, 2006
PR Newswire (press release),Two additional studies also released at the meeting report the pharmacokinetic profile of guanfacine extended release. Shire submitted a New Drug

Shire Guanfacine Shows ADHD Improvement  -  Nov 17, 2006
Forbes,In a study of 345 children, subjects were given either guanfacine extended release or a placebo and then tested using an ADHD rating scale.

Post-trauma drug useless?  -  Dec 4, 2006
Health24.com,In the first-ever randomised, placebo-controlled trial of guanfacine for the alleviation of post-traumatic stress disorder (PTSD), "we found that it really

Common PTSD Drug May Be Useless  -  Dec 1, 2006
WWAY NewsChannel 3,In the first-ever randomized, placebo-controlled trial of guanfacine for the alleviation of post-traumatic stress disorder (PTSD), "we found that it really

Common post-traumatic stress disorder drug has "zero" effectiveness  -  Dec 3, 2006
DailyIndia.com,The study, conducted by researchers at the San Francisco VA Medical Center found that Guanfacine does not offer any benefit, but on the contrary has several

Common Post-Traumatic Stress Disorder Drug Is No More Effective ...  -  Dec 1, 2006
DG NewsGuanfacine belongs to a class of medications known as alpha-2 agonists, which lower the brain's supply of the neurotransmitter norepinephrine.

Placebo Equal To PTSD Drug  -  Dec 1, 2006
PsychCentral.com,Guanfacine is often prescribed for PTSD yet researchers from the San Francisco VA Medical Center found the medication was not beneficial and if fact was

New Shire ADHD Drug Effective  -  Nov 17, 2006
TheStreet.comBased on study results on patients aged 6 to 17 years old, the drug, guanfacine extended release, significantly improved symptoms of ADHD when used by

Shire says GXR improves symptoms in ADHD patients aged 6-17  -  Nov 17, 2006
Forbes,Shire PLC said that daily doses of the investigational medication guanfacine extended release (GXR) significantly improved symptoms of

Shire says extended release ADHD drug effective  -  Nov 17, 2006
Reuters.uk,L: Quote, Profile, Research) said on Thursday that a Phase III trial of its experimental drug guanfacine extended release showed that it significantly

FTSE slips in commodities bloodbath, M&A submerged  -  Nov 17, 2006
Reuters South Africa,Drugmaker Shire jumped 2.1 percent after it said it had completed a successful trial of its Attention-Deficit/Hyperactivity Disorder drug guanfacine.

Shire's extended release ADHD drug effective  -  Nov 16, 2006
Reuters.uk,LOS ANGELES (Reuters) - Shire said on Thursday that a Phase III trial of its experimental drug guanfacine extended release showed that it significantly

Shire Analysis Compares Stimulant To Nonstimulant ADHD Medications ...  -  Nov 23, 2006
Medical News Today (press release),...government regulation and approval, including but not limited to the expected product approval dates of SPD503 (guanfacine extended release) (ADHD),

FTSE slips in commodities bloodbath, M&A submerged  -  Nov 17, 2006
ReutersProfile, Research) jumped 2.1 percent after it said it had completed a successful trial of its Attention-Deficit/Hyperactivity Disorder drug guanfacine.

Sección internacional  -  Nov 16, 2006
Bolsamania.com,...(PRN) - Shire Announces Study Results With Once-Daily Guanfacine Extended Release (GXR) in ADHD Patients Aged 6-17 ... [+]. (PRN) - Vista Announces Results

Wal-Mart's $4 Generics Program Launched In Final 11 States  -  Nov 27, 2006
PR Newswire (press release),Furosemide 40MG TAB Furosemide 80MG TAB Guanfacine 1MG TAB Hydralazine 10MG TAB Hydralazine 25MG TAB Hydrochlorothiazide 12.5MG CAP* Hydrochlorothiazide

Wal-Mart Brings $4 Generics Program to Massachusetts  -  Nov 16, 2006
Yahoo! News (press release)Furosemide 40MG TAB Furosemide 80MG TAB Guanfacine 1MG TAB Hydralazine 10MG TAB Hydralazine 25MG TAB Hydrochlorothiazide 12.5MG CAP Hydrochlorothiazide

Shire Announces NDA Submission of Guanfacine Extended - Release ...  Aug 27, 2006
...that it has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for its investigational compound guanfacine extended release ... -HealthNewsDigest.com

Shire seeks FDA approval for ADHD treatment guanfacine extended ...  Aug 24, 2006
...said it has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for its investigational compound guanfacine extended release ... -Life Style Extra

Shire Seeks Approval for New ADHD Drug  Aug 25, 2006
...broaden its ADHD portfolio, Shire has submitted a new drug application to the FDA seeking approval for its investigational compound, guanfacine extended release ... -International News Service

Shire Looks to Launch New ADHD Drug  Aug 24, 2006
The active ingredient in Shire's Connexyn is guanfacine, the same ingredient in a blood pressure medication that has been available in the US for 20 years and ... -TheStreet.com

UPDATE 1-Shires files new ADHD drug for approval in US  Aug 24, 2006
Britain's third-biggest drugmaker said experimental drug guanfacine extended release -- previously known as SPD503 -- would, if approved, be the first once ... -Reuters

Shire seeks OK on nonstimulant ADHD drug  Aug 24, 2006
...drug. Expected to be called Connexyn, the drug for 6- to 17-year-olds will employ guanfacine, an alpha-2A-adrenoceptor agonist. ... -Bizjournals.com

Shire seeks FDA approval for ADD drug  Aug 24, 2006
SHPGY), which has headquarters operations both in the United Kingdom and Philadelphia, said it had filed a new drug application for guanfacine extended release ... -Bizjournals.com

Shire files for OK of ADHD drug for kids  Aug 24, 2006
24 (UPI) -- Shire said Thursday it has filed for US approval of guanfacine extended release for attention deficit hyperactivity disorder in kids. ... -United Press International

Myogen Reports 2006 Second Quarter Results  Aug 7, 2006
Approximately 770 patients will be randomized to darusentan,active control (guanfacine, an antihypertensive drug that acts as acentral alpha agonist) or placebo ... -Finanzen.net

Checklist for Camp: Bug Spray. Sunscreen. Pills.  Jul 15, 2006
Here, children jostle for their morning medications: Zoloft for depression, Abilify for bipolar disorder, Guanfacine for twitchy eyes and a host of medications ... -New York Times

New norm for kid camp: pills before thrills  Jul 15, 2006
Here, children jostle for their morning medications: Zoloft for depression, Abilify for bipolar disorder, Guanfacine for twitchy eyes and others for attention ... -Houston Chronicle

`Meds' now daily part of summer camp ritual  Jul 16, 2006
Echo starts at a picnic table where children jostle for their morning medications: Zoloft for depression, Abilify for bipolar disorder, Guanfacine for twitchy ... -Chicago Tribune

Camp fixtures: bugs, s'mores — and pills  Jul 16, 2006
Echo starts at a picnic table where children jostle for their morning medications: Zoloft for depression, Abilify for bipolar disorder, guanfacine for twitchy ... -Seattle Times

Prognosis of Tics and Obsessive-Compulsive Disorder in Children ...  Jun 30, 2006
ADHD in 22% of patients, depression in 33%, bipolar disorder in 4%, and schizophrenia in 1. Medications for the treatment of tics (guanfacine or clonidine ... -AAP Grand Rounds (subscription)



Behavioral and Pharmacologic Treatment of Aggression in Children ...  May 10, 2006
Guanfacine, a longer-acting α2-adrenergic agonist, was only effective in 19 of 80 (24%) patients with PDD at mean treatment duration of one year (Posey et al ... - Psychiatric Times

Myogen Reports 2006 First Quarter Results  May 8, 2006
Approximately 770 patients will be randomized to darusentan, active control (guanfacine, an antihypertensive drug that acts as a central alpha agonist) or ... - Genetic Engineering News

Ped Med: ADHD Drug Remedies Hit and Miss  Apr 21, 2006
...antidepressants, such as the tricyclics Imipramine or Desipramine or bupropion (Wellbutrin), anti-hypertension medications like guanfacine (Tenex) or clonidine ... - National Ledger





OUR CHILDREN'S BRAINS - Pt 6  Mar 30, 2006
Similar, less well-known pharmaceuticals such as clonidine, guanfacine, risperidone, ziprasidone, clonazepam, and selective serotonin reuptake inhibitors (SSRIs ... - LongIslandPress.com



Monoaminergic Treatment of Schizophrenia  Feb 27, 2006
Guanfacine (Tenex), by enhancing signals at postsynaptic α 2 -adrenergic receptors, has been shown to improve working memory performance in animal models ... - Psychiatric Times,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional